Pharmaceutical intermediates
Tucatinib Intermediates
17 pharmaceutical intermediates for Tucatinib. Indication: Breast cancer; colorectal cancer.
About Tucatinib
- Originator
- Array Biopharma
- Indication
- Breast cancer; colorectal cancer
- Approved Date
- 04/17/2020
- NCE Patent
- 04/17/2025
- DS/DP
- 11/16/2025
Available intermediates
17 intermediates currently listed for Tucatinib. Request specifications, documentation or a quotation for any item below.
| Product Name | CAS No. | Molecular Formula | Physical Properties |
|---|---|---|---|
| [1,2,4]Triazolo[1,5-a]pyridin-7-ol | 1033810-70-6 | / | / |
| (E)-N'-(2-cyano-4-(3-(1-hydroxy-2-methylpropan-2-yl)thioureido)phenyl)-N,N-dimethylformimidamide | 1429755-57-6 | / | / |
| (2-methyl-4-nitrophenoxy)-[1,2,4]triazolo[1,5-a]pyridine | 937263-44-0 | / | / |
| 4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)-3-methylaniline | 937263-71-3 | / | / |
| (E)-N'-(2-cyano-4-nitrophenyl)-N,N-dimethylformimidamide | 39263-34-8 | / | / |
| N'-(4-Amino-2-cyanophenyl)-N,N-dimethylformamidine | 194423-17-1 | / | / |
| Chloro-[1,2,4]triazolo[1,5-a]pyridine | 1427452-48-9 | / | / |
| 1-(4-((4-([1,2,4]Triazolo[1,5-a]pyridin-7-yloxy)-3-methylphenyl)amino)quinazolin-6-yl)-3-(1-hydroxy-2-methylpropan-2-y | 1429755-58-7 | / | / |
| 1-(3-cyano-4-((dimethylamino)methyleneamin | 937263-23-5 | / | / |
| (4-chloropyridin-2-yl)-N'-hydroxyformimidamide | 2379814-46-5 | / | / |
| Aminopyridin-4-ol | 33631-05-9 | / | / |
| 4-Chloropyridine-2-carboxamide | 99586-65-9 | / | / |
| Methyl 4-chloropicolinate | 24484-93-3 | / | / |
| 2-Amino-4-chloropyridine | 19798-80-2 | / | / |
| 2-Amino-4-methoxypyridine | 10201-73-7 | / | / |
| 4-METHOXY-PYRIDINE-2-CARBOXYLIC ACID AMIDE | 90151-10-3 | / | / |
| 5-Chloropyridine-2-carboxylic acid | 5470-22-4 | / | / |
我们能如何帮助您？
获取最新活动与法规动态洞察
直接发送到您的邮箱
在此获取行业洞察与 Unibest 动态
联系我们 →